Despite a wealth of information about the structure of surface membrane immunoglobulin (smIg) on CLL cells, little is known about epitopes reacting with their binding sites. Probing phage-displayed peptide libraries, we identified and characterized mimetopes for Igs of 4 patients with mutated (M-CLL) and 4 with unmutated (U-CLL) IGHV. Six of these mAbs were representatives of stereotyped B-cell receptors characteristic of CLL.
Introduction
Chronic lymphocytic leukemia (CLL), the most frequent adult leukemia among Caucasians, follows a heterogeneous clinical course 1, 2 . In ~50% of cases, leukemic clones display somatically mutated immunoglobulin (Ig) heavy (H) chain variable (IGHV) genes (M-CLL) 3 , and patients with M-CLL follow a much more favorable clinical course than patients with unmutated IGHV (U-CLL) [4] [5] [6] . Based on phenotypic analyses 7 and gene expression profiling 8, 9 , both M-CLL and U-CLL appear to derive from antigen-experienced B cells.
Therefore clonal selection by antigen is likely responsible for skewing the IGHV repertoires of both M-and U-CLL compared to normal B cells and to each other 3, 10 .
In CLL, certain IGHVs recombine frequently with distinct IGHD and IGHJ, thereby creating highly similar H chain complementarity-determining region (CDR) 3 sequences [11] [12] [13] [14] [15] [16] [17] ; these "stereotyped" receptors 13 Collectively, these observations support antigenic selection and stimulation as playing roles in the development and evolution of CLL. Whether this selection culls susceptible cells from the entire B-cell pool or from a pre-biased subset 13, 18 remains to be determined, although gene expression studies suggest that the susceptible pool is homogeneous 8, 9 .
Selecting antigens for CLL Igs are largely unknown, although some Ig-reactive autoantigens have been defined [19] [20] [21] [22] . This reactivity is more promiscuous among U-CLL than M-CLL monoclonal antibodies (mAbs) 22 . Furthermore, many CLL Igs exhibit structural features resembling mAbs reactive with microbial antigens 18 .
The present study was undertaken to identify mimetic epitopes of CLL mAbs and to characterize differences in epitope reactivity between U-and M-CLL. Since little is known about the chemical nature of important antigens, i.e., if they are proteins, carbohydrates, or lipids, peptide phage display technology was used to identify ligands for CLL mAbs. This approach has successfully identified mimetic epitopes of proteins 23 , carbohydrates [24] [25] [26] , lipids 27 , and DNA 28 .
Our data indicate that phage display is a feasible technique to identify and characterize ligands binding to M-CLL and U-CLL Igs. These ligands differ in structural characteristics:
those binding M-CLL mAbs exhibit clearly definable, extended amino acid motifs, while those interacting with BCRs of U-CLL do not. The data suggest that somatic hypermutation that shapes the antigen-binding site influences the level of epitope specificity for an individual CLL BCR.
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Materials and Methods
Expression of recombinant CLL Ig molecules. The variable segments of rearranged IGH and IGL of CLL clones were expressed as human IgG1s as previously described 22, 29, 30 . The molecular characteristics of these mAbs are listed in Table 1 .
Probing of peptide phage display libraries with CLL mAbs. 
Enzyme immunoassays.
Phage ELISA. Polystyrene plates (Nunc, Roskilde, Denmark) were coated with PEGpurified phages (50µl), serially diluted in PBS. After washing with PBS-Tween 0.1%, CLL mAb (50µl of 2µg/ml) was incubated at room temperature for 3 hours. Plates were washed with PBS-Tween 0.1% and incubated for 1 hour at room temperature with horseradish peroxidaseconjugated goat anti-human IgG (Southern Biotech, Birmingham, AL). Plates were developed for 15 minutes with TMP Sure Blue 1-component substrate (KPL, Gaithersburg, MD), stopped with 1M HCl, and absorbance measured at 450nm. In some instances (CLL mAbs 014, 255, and 270), direct phage ELISA was performed as described 31 .
Peptide ELISA. Peptides, amidated and biotinylated at the C terminus, were synthesized by Princeton Biomolecules (Langhorne, PA). Polystyrene plates, coated with streptavidin (10µg/ml; New England Biolabs) overnight at 4°C, were blocked with HSA 10%, and biotinylated peptides (2µg/ml) added. After washing with PBS-Tween 0.1%, wells were incubated with serially diluted CLL mAb (50µl) at room temperature for 2 hours. ELISAs were developed and quantified as described above.
Computational comparisons of peptide sets isolated from phage display libraries. Pairwise alignment scores were computed for each pair of peptide sequences for each mAb using a dynamic programming tool available on the EMBL-EBI website. Optimal scores for pairwise 6
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From alignments were determined using Gonnet matrices for matches/mismatches between amino acids with default penalties for insertions and deletions. Multiple alignment was performed for peptide sets of each mAb using the ClustalW2 multiple sequence alignment tool 32 Peptides reactive with soluble M-CLL and U-CLL mAbs differ in structural properties.
The Ph.D.-12 peptide phage display library was probed with each CLL mAb using conditions that favor more specific and avid peptide-mAb interactions. After 3 rounds of selection, 15-30 phages were isolated for each mAb; most of these phages contained peptide inserts (Supplemental Tables 1 and 2 ).
Peptides isolated by M-CLL mAbs differed significantly from those isolated by U-CLL mAbs. For the M-CLL mAbs, a large number of related but usually non-redundant peptides 8
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From were found (Table 2 and Supplemental Table 1 ). These peptides displayed clear motifs that contained 6-8 identical or chemically related amino acids with shorter stretches of contiguity (Table 2) . Furthermore, the occurrence rates of these key amino acids at the defined positions ranged from 50-100%, depending on the M-CLL peptides examined (Supplemental Table 1 ).
In contrast, U-CLL mAbs bound a series of peptides that did not contain amino acid motifs or exhibited motifs of much inferior quality ( Table 2 ). In addition, one phage clone of those isolated with U-CLL mAbs was often numerically dominant, a feature that was far less obvious for phages isolated by M-CLL mAbs (Supplemental Tables 1 and 2 ). However, difference in evaluable sequences was not the sole determinant of a lack of motifs, since for U-CLL mAb270 16 non-redundant sequences were available for study and a motif was not identified ( Table 2 ).
Since U-CLL mAbs are known to be polyreactive [19] [20] [21] [22] and often bind antigens with low affinity, we tested if altering the mAb's form and valency would affect the selection of phages, thereby resulting in the isolation of clones with shared amino acid motifs, as for M-CLL mAbs.
After chemically linking mAb114 to Sepharose beads, selection was performed as in solution.
Using this approach, 5 of 29 clones with inserts (Supplemental Table 3 ) contained the identical sequence (WHDDQMLRRTVT) that had been detected when the mAb was used in soluble form (Supplemental Table 2 ). In addition, a more dominant clone (13/29 phages) with the insert WNLRDTCYPYCT was also found (Supplemental Table 3 ). Unlike with solution phase isolation, peptides with a sequence motif were detectable by solid phase probing, although the motif was less resolved than those found using M-CLL mAbs and had multiple positions with disparate amino acids (Supplemental Table 3 ). Thus by changing the form and valency of a U-CLL mAb, peptides with greater resemblance to those found with M-CLL mAbs were isolated. Table 1A ). For mAb183, binding to specific phage clones followed proportionately the number of residues present in the motif, except for 183-15 which mismatched at 4 positions and was essentially non-reactive ( Figure 1B and Supplemental Table 1B) .
Similarly, alterations in the defined motif dramatically reduced binding to clones 412-2 and 412-6, which shared only the central YHH portion of the motif ( Figure 1D and Supplemental Table   1D ).
As for M-CLL mAbs, each U-CLL mAb bound phages selected in the initial isolations (Figure 1E-H).
Peptide motifs identified by M-CLL mAbs are better defined. M-CLL-derived peptide motifs were more clearly defined and comprised a greater number of common amino acids in the same sequence (Table 2) . To place these differences on a firm mathematical footing, we analyzed pairwise alignment scores and edit distances. Pairwise alignment scores measure the sequence similarity of any two peptides selected by the same mAb. After pooling these scores ; Figure 2A ), indicating that any two peptides in a pair isolated by a single M-CLL mAb were more similar to one another than those isolated by U-CLL mAbs.
Thus, as a group, M-CLL-derived peptides cluster more tightly than U-CLL-derived peptides. In a similar analysis using pairwise edit distances computed on pairs of aligned sequences, the two distributions were significantly different (Student t-test: P = 3.76x10 -20 ; Figure 2B ), demonstrating that not only were peptides isolated by a single M-CLL mAb more similar to one another, they also allowed for a greater degree of alignment.
Binding of M-and U-CLL mAbs to synthetic peptides from selected phage clones.
Since peptides displayed on the surface of phages can lose reactivity with a selecting mAb when expressed as independent molecules, we synthesized peptides corresponding to the sequences of phages selected by M-and U-CLL mAbs and determined their binding. Representative peptides isolated by M-CLL mAbs 169, 183, and 412, and by U-CLL mAbs 068 and 114 were synthesized with biotin at the C-terminus to permit binding to streptavidin. This format allowed us to perform enzyme immunoassays and immunofluorescence analyses. For each peptide, a scrambled version containing the same amino acids, but in a different order, was also synthesized to determine if binding was due to amino acid composition alone or a particular sequence.
There was dose-dependent binding of mAb169 to peptide 169-2, starting at 400ng/ml ( Figure 3A) , and to peptide 169-8 ( Figure 3B ), beginning at 10ng/ml; this was not observed for the corresponding scrambled peptides ( Figure 3E and 3F) . For M-CLL mAb183, no specific binding was detected for two peptides, 183-2 and 183-4 (not shown). Therefore, we synthesized
11
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From a peptide, "183-adapted" (FSYSKDLLRTLL), taking into account sequences of the peptidephages that were bound best by mAb183 in ELISA (Supplemental Figure 1) . This peptide showed enhanced reactivity with mAb183 ( Figure 3C ).
To discriminate the key amino acid residues involved in mAb412 recognition of peptide 412-9 ( Figures 3D and 4) , shorter stretches of the full length peptide were synthesized. Because peptide 412-9 (YHHAYLLPPPRM) had a highly polar N-terminus and a markedly hydrophobic C-terminus, synthetic peptides corresponding to the two poles of the original sequence were synthesized (412-9-1: YHHAYL, and 412-9-3: LPPPRM; Figure 4 ). In addition, fragments spanning the junction between the above two peptides were also made (412-9-2: YHHAYLLP, Table 1 ), were bound very well by their selecting mAb and were essentially non-reactive for other M-and U-CLL mAbs tested ( Figure 3A and B) .
Somewhat unexpectedly, M-CLL peptides 412-9 and 183-adapted, isolated by M-CLL mAbs with mid-range somatic mutations (Table 1) , bound effectively to mAbs not involved in their selection. Thus, M-CLL peptide 183-adapted interacted efficiently with U-CLL mAb114 ( Figure 3C) ; likewise, peptide 412-9 reacted very efficiently with M-CLL mAbs 169 and 183 as well as U-CLL mAbs 068 and 114 ( Figure 3D ). Not surprisingly, this phenomenon also occurred with peptides isolated by polyreactive U-CLL mAbs 068 and 114 (068-4 and 114-1) that recognized both U-CLL mAbs as well as M-CLL mAb183 ( Figure 5A and B).
Viewed from the mAb side, U-CLL mAbs 068 and 114 had a broader reactivity profile, reacting with their homologous peptides ( Figures 5A and B , respectively) as well as heterologous peptides isolated by either U-CLL or M-CLL mAbs. Specifically, mAb114 bound peptides 068-4 ( Figure 5A ), 183-adapted ( Figure 3C ), and 412-9 ( Figure 3D) ; likewise mAb 068 bound peptides 114-1 ( Figure 5B ) and 412-9 ( Figure 3D ), and had lesser reactivity to peptide 183-adapted ( Figure 3C ). These data were consistent with the polyreactivity of U-CLL mAbs 22, 29, 30 .
Of interest, M-CLL mAb169 reacted well not only with its homologous peptides ( Figure   3A and B) but also with M-CLL peptide 412-9 ( Figure 3D ), even though the 169-2 and 169-8 peptides do not share obvious similarity in motif with peptide 412-9 ( Table 2 ). This was surprising because mAb169 does not react in enzyme immunoassays with a large panel of (auto)antigens 22, 29 , and the peptides it isolated (169-2 and 169-8) reacted solely with itself ( Figures 3A and B) . Thus, a significantly mutated CLL mAb that can identify a very specific ligand from the multitude contained in the phage library can still act somewhat non-specifically by binding ligands isolated by other CLL mAbs.
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Finally, M-CLL and U-CLL mAbs were analyzed for binding to various scrambled peptides. M-CLL mAbs 169 and 412 were essentially non-reactive with these variants, although M-CLL mAb183 reacted at the highest concentration tested (50µg/ml; Figure 3 ). In contrast, U-CLL mAbs 068 and 114 bound scrambled versions of peptides 068-4 and 114-1, slightly at 10µg/ml and effectively at 50µg/ml, respectively ( Figure 5C and D) .
Inhibition of CLL mAb binding to "native" antigen by a mimetope.
We recently demonstrated that mAb183, a member of stereotyped subset 4, binds the surface of viable human B (but not T) cells 36 . Therefore, we tested the extent to which peptide 183-adapted and its scrambled version inhibited this natural autoreactivity. As illustrated in Figure 6 , mAb183 
Discussion
The aim of this study was to characterize the binding properties of CLL BCRs using phage-displayed 12-mer peptides. We tested 8 CLL mAbs, which differed in IGHV mutation status, amino acid structure, and associated clinical outcomes, to identify antigenic epitopes, determine the extent to which these differed between U-and M-CLL, and begin testing the functional activities of mimetic ligands in vitro.
Based on current information, antigenic targets of U-CLL and M-CLL Igs/mAbs differ.
Both types can be autoreactive [19] [20] [21] , but U-CLL mAbs far outstrip M-CLL in this regard as well as in polyreactivity 22 . 
Characteristics of epitopes bound by M-and U-CLL mAbs. Using isolation conditions that
favor selection of more specific and avid antigen/antibody interactions, we identified ligands for each CLL mAb. The characteristics of these ligands differed considerably, and this related to the
15
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From structure of the selecting Ig. Whereas M-CLL mAbs recognized multiple phage-displayed peptides that shared common amino acid motifs (Table 2 and Supplemental Table 1 ), U-CLL mAbs bound peptide sets that were frequently dominated by individual sequences that occurred repeatedly but did not share amino acids (Table 2 and Supplemental Table 2 ). The isolation of numerically dominant peptide-phages seems paradoxical. However, it appears that low affinity mAb-peptide interactions often fail to isolate, especially in the initial rounds of the probing process, phages bearing unique and specific peptide sequences; rather these low affinity mAbs bind a broad range of disparate phages 24, 25, 31, 40, 41 . This lack of "specificity" then permits those phages that grow the fastest to be amplified and enriched at each round; ultimately this can lead to isolation of multiple phages expressing identical peptide sequences. This is not necessarily an indicator of greater binding specificity, but in fact may be the opposite, i.e., low affinity, multireactivity. Finally, U-CLL mAbs did not necessarily identify the same dominant peptides when probed additional times (Supplemental Table 3 and data not shown).
On testing individual peptide-phage clones isolated from the 12-mer peptide-phage library, it was clear that for M-CLL mAbs slight variations in key amino acid motifs of the peptides changed or abolished binding ( Figure 1A-D) . Thus, peptides isolated with M-CLL mAbs can be highly specific for individual BCRs, representing defined epitopes of shared amino acids.
For one U-CLL mAb (114), the form and valency of the antibody (soluble dimeric or insoluble multimeric), appeared important, since the peptides isolated by the same mAb differed when the mAb format was altered. Specifically, changes in form and valency to insoluble multimeric altered the structure of the peptides captured from U-CLL-like to more M-CLL-like
16
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Finally, although U-CLL mAbs are typically "polyreactive", U-CLL mAb068 efficiently bound to its selected peptide ( Figure 5A ), even at a low concentration (400ng/ml). Thus, U-CLL mAbs, which resemble natural antibodies, may have inherent, preferential specificity for certain yet-to-be-defined determinants in vivo. The reactivity of unmutated, natural antibodies with unique epitopes on human influenza viruses is consistent with this concept 42, 43 .
Identification of key residues in peptides isolated with CLL mAbs. Common sequence motifs (Table 2) (Table 2) . M-CLL mAb 412 also had a prominent Y contained within a consistent YHH motif (Table 2) .
We have searched the amino acid sequences of MYHIIA and vimentin, which we know react with CLL mAbs 068 and 114, respectively 30 , to determine if they contain residues found in the peptides isolated by these mAbs. Although there is no exact match of the peptides to any protein in the GenBank database, there is a weak match of the 068 peptide (3/12 residues) to 17
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MYHIIA; this degree of similarity is analogous to that observed for a phage display peptide binding a mouse antibody that recognizes MYHIIA 44 . There is a somewhat better, albeit still weak match for vimentin by 114-1 peptide (4/12 residues). These data are provocative, although not definitive, and are being analyzed further.
The amino acid commonality between peptides isolated by distinct M-CLL mAbs suggests a restricted set of immunoreactive epitopes in the antigens that drove these B-cell clones, before and possibly after leukemic transformation. These core residues may permit a definition of peptides that are even more specific for individual CLL BCRs/mAbs or for members of stereotyped subsets within which they reside. Furthermore, amino acid commonality may reflect an innate reactivity of CLL mAb binding domains with classes of antigenic epitopes for which there has been evolutionary conservation of paratope structure, for example (but not limited to) viruses; these conserved structures can be modified and lose this antigen-binding function as IGHV and IGKV or IGLV change due to somatic mutations.
Mono-, oligo-, and poly-reactivity of CLL mAbs and the peptides they select. Our studies indicate that peptides reactive with CLL mAbs can display different degrees of specificity, and this correlated with the level of structural change within the antigen-binding site of the selecting mAb. Peptides 169-2 and -8, isolated by M-CLL mAb169 that exhibits 10 replacement mutations, were specific for their selecting mAb. Peptides 412-9 and 183-adapted were less specific, exhibiting a level of promiscuity consistent with the degree of somatic mutation in the M-CLL mAbs that had isolated them (3 and 4 replacement mutations, respectively). Peptides 068-4 and 114-1, isolated by U-CLL mAbs 068 and 114 with no or 1 replacement mutation, respectively, reacted with most/all of the mAbs tested (Figures 3 and 5 ).
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The latter findings are consistent with several different peptides binding the paratope of a single CLL mAb. This phenomenon has been documented for germline antibodies 40, 41 , in agreement with our data for U-CLL. Surprisingly, we found the same for M-CLL mAbs.
Although the ability of more than one peptide to bind to a single mAb binding site related to the level of IGHV somatic mutations present in the mAb (U-CLL > M-CLL), this was not absolute.
The antigen-binding site of the highly mutated mAb169 could be occupied by peptides selected by another M-CLL mAb (183; Figure 3C ), and the paratope of the less mutated M-CLL mAb183
could accommodate U-CLL peptide 068-4 ( Figure 5A ). There is no a priori reason that any ligand will not be bound by a given receptor; however, since in most settings IGHV mutated mAbs tend to bind more specifically to epitope targets, one might expect that such bound epitopes would be more specific for the selecting mutated mAb than others. Thus, although somatically mutated antigen-binding sites such as in M-CLL can be shaped to bind more defined determinants, this re-modeling may not completely exclude "nonspecific" binding regions or regions that serve as superantigen binding sites. The latter may be relevant for mAb183, which as a member of subset 4 expresses IGHV4-34 that can bind N-acetyllactosamine through key residues in the FR1 region 45 . Of note, these residues are conserved in mAb183 and in most IGHV4-34-utilizing CLL mAbs in subset 4 17 .
Finally, in vivo our data suggest that multiple distinct structural epitopes could bind M- 32 . Peptide motifs were identified by requiring 50% amino acid identity or chemical similarity for positions at which 6 or more residues were available; a score of 66.7% was required when <6 residues were present at a given alignment position. The following list of chemical similarities was used for these assignments: Ali(phatic): A. Pairwise alignment scores. Pooled pairwise alignment scores for M-CLL peptides were significantly higher than those of U-CLL peptides (Student t test: P = 2x10 -16 ).
B. Pairwise edit distances. As a group, M-CLL peptides had significantly shorter pairwise distances than U-CLL peptides (Student t-test: P = 3.76x10 -20 ). 
